Nonetheless, decreased expression of Fas and/or increased expression of FasL has been detected in multiple types of human cancer, including lung cancer, and appears to be a feature of the malignant phenotype, suggesting that the Fas/FasL system may play an important role in cancer formation [144,145]. This evidence concerns the gene FAS and lung cancer.